Who makes [14C]-Poziotinib?

[14C]-Poziotinib is developed by Spectrum Pharmaceuticals, Inc.

What development phase is [14C]-Poziotinib in?

[14C]-Poziotinib is in Phase 1.

Last reviewed 2026-04-19 · How we verify

[14C]-Poziotinib

Spectrum Pharmaceuticals, Inc · Phase 1 active Small molecule

At a glance

Generic name	[14C]-Poziotinib
Sponsor	Spectrum Pharmaceuticals, Inc
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]-Poziotinib CI brief — competitive landscape report
[14C]-Poziotinib updates RSS · CI watch RSS
Spectrum Pharmaceuticals, Inc portfolio CI